Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer

Introduction: Prostate cancer is the second leading cause of cancer-related death among American men. Prostate tumor cells exhibit significant tropism for the bone and once metastasis occurs, survival rates fall significantly. Current treatment options are not curative and focus on symptom managemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Shreya, Mulia, Grace E., Figueiredo, Marxa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568464/
https://www.ncbi.nlm.nih.gov/pubmed/37842640
http://dx.doi.org/10.3389/fmolb.2023.1259336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568464/
https://www.ncbi.nlm.nih.gov/pubmed/37842640
http://dx.doi.org/10.3389/fmolb.2023.1259336

Ejemplares similares